bf/NASDAQ:AKBA_icon.png

COM:AKEBIA

Akebia Therapeutics, Inc.

  • Stock

USD

Last Close

1.82

22/11 21:00

Market Cap

226.36M

Beta: -

Volume Today

1.99M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
57.12M
-
115.30M
101.84%
88.68M
23.08%
49.61M
44.06%
29.98M
39.57%
18.73M
37.53%
average payables
566.04K
-
1.37M
141.60%
2.17M
58.46%
2.18M
0.42%
4.52M
107.65%
24.90M
451.00%
41.01M
64.70%
40.26M
1.81%
37.45M
6.99%
25.80M
31.09%
16.33M
36.72%
average receivables
110.49K
-
91.67K
17.03%
24K
73.82%
16.91M
70,364.58%
34.02M
101.16%
25.44M
25.22%
27.77M
9.13%
32.86M
18.35%
38.86M
18.28%
45.03M
15.86%
39.23M
12.86%
book value per share
1.60
-
6.76
323.23%
4.95
26.74%
1.81
63.51%
2.74
51.89%
5.44
98.33%
3.33
38.72%
1.79
46.36%
0.46
74.24%
0.05
88.91%
-0.16
419.20%
capex per share
-0.00
-
-0.01
1,351.45%
-0.02
5.23%
-0.07
351.24%
-0.04
47.17%
-0.01
63.15%
-0.06
309.10%
-0.00
95.93%
-0.00
84.47%
-0.00
75.43%
capex to depreciation
-15.39
-
-4.67
69.64%
-4.31
7.72%
-8.99
108.54%
-2.63
70.77%
-0.66
74.77%
-0.17
74.04%
-0.01
94.52%
-0.00
83.53%
-0.00
94.62%
capex to operating cash flow
0.00
-
0.01
378.51%
0.01
5.19%
-0.05
681.93%
0.03
162.83%
0.02
42.97%
0.03
56.93%
0.00
88.89%
0.00
91.88%
0.00
568.15%
capex to revenue
-1.73
-
-0.01
99.47%
-0.01
15.17%
-0.02
156.97%
-0.00
94.60%
-0.00
74.27%
-0.00
41.04%
cash per share
1.69
-
7.07
318.41%
5.23
26.01%
6.90
31.96%
7.31
5.84%
2.75
62.33%
1.25
54.67%
1.94
55.56%
0.90
53.48%
0.49
45.17%
0.23
53.74%
days of inventory on hand
5.43K
-
292.20
94.61%
75.26
74.24%
90.88
20.75%
93.67
3.07%
75.62
19.27%
days payables outstanding
2.03K
-
98.49
95.15%
50.95
48.27%
79.92
56.85%
77.57
2.94%
70.53
9.07%
days sales outstanding
8.04K
-
70.17
99.13%
29.28
58.27%
42.34
44.61%
33.19
21.62%
86.94
161.96%
48.87
43.79%
73.69
50.77%
debt to assets
0.00
-
0.00
-
0.02
566.81%
0.14
677.37%
0.20
39.58%
0.26
32.04%
0.28
9.56%
0.39
38.93%
debt to equity
0.00
-
0.01
-
0.03
242.33%
0.27
869.12%
0.51
85.86%
1.78
248.91%
10.68
500.26%
-3.11
129.15%
dividend yield
earnings yield
-0.03
-
-0.21
706.87%
-0.18
14.03%
-0.35
94.73%
-0.12
65.61%
-0.27
123.66%
-0.37
40.53%
-0.90
141.45%
-0.65
27.65%
-1.01
53.95%
-0.22
77.78%
enterprise value
493.25M
-
146.55M
70.29%
292.20M
99.39%
205.30M
29.74%
576.70M
180.91%
556.74M
3.46%
709.14M
27.37%
285.28M
59.77%
361.29M
26.64%
114.78M
68.23%
293.71M
155.89%
enterprise value over ebitda
-33.14
-
-3.87
88.33%
-4.76
23.01%
-1.51
68.31%
-7.27
382.34%
-3.13
57.02%
-2.48
20.74%
-0.76
69.40%
-1.36
79.69%
-2.48
81.89%
-69.45
2,704.11%
ev to operating cash flow
-43.53
-
-5.33
87.75%
-5.58
4.56%
3.55
163.59%
-10.27
389.65%
-5.71
44.39%
-2.75
51.76%
-2.58
6.18%
-1.43
44.74%
-1.57
9.86%
-12.56
700.51%
ev to sales
133.74
-
3.24
97.58%
2.68
17.29%
2.12
21.01%
0.97
54.36%
1.69
75.11%
0.39
76.81%
1.51
284.71%
free cash flow per share
-0.59
-
-1.80
205.32%
-2.00
10.94%
1.46
173.40%
-1.33
190.69%
-0.85
36.17%
-2.23
163.10%
-0.80
64.16%
-1.52
90.70%
-0.40
73.71%
-0.12
68.88%
free cash flow yield
-0.02
-
-0.15
600.35%
-0.15
0.05%
0.14
191.09%
-0.09
163.49%
-0.15
71.63%
-0.35
130.21%
-0.29
19.10%
-0.67
136.27%
-0.69
2.97%
-0.10
85.52%
graham net net
1.49
-
6.62
343.90%
4.78
27.83%
1.42
70.26%
2.27
59.35%
0.26
88.42%
-1.19
555.55%
-0.56
53.34%
-1.46
161.65%
-1.16
20.57%
-1.02
11.57%
graham number
4.95
-
19.11
285.84%
15.98
16.39%
12.09
24.33%
10.45
13.62%
13.42
28.44%
13.31
0.79%
10.08
24.25%
3.91
61.21%
0.82
79.12%
1.01
23.47%
income quality
0.86
-
0.74
13.77%
0.86
16.31%
-0.43
149.42%
0.73
271.17%
0.68
7.01%
0.92
35.58%
0.29
68.73%
0.89
210.68%
0.79
11.63%
0.45
43.02%
intangibles to total assets
0
-
0
0
0
0
0.38
Infinity%
0.45
16.76%
0.31
31.12%
0.31
0.39%
0.36
16.38%
0.39
8.87%
interest coverage
-22.65
-
-184.17
713.27%
-120.61
34.51%
-151.45
25.57%
-28.55
81.15%
-28.95
1.38%
42.44
-
13.31
68.64%
-4.03
130.26%
-7.64
89.65%
interest debt per share
0.04
-
0.01
63.99%
0.02
44.10%
0.02
23.98%
0.09
264.33%
0.21
137.49%
0.91
342.64%
0.85
7.32%
0.70
17.49%
0.63
9.71%
0.54
14.49%
inventory turnover
0.07
-
1.25
1,756.97%
4.85
288.24%
4.02
17.19%
3.90
2.98%
4.83
23.87%
invested capital
0.00
-
0.01
-
0.03
242.33%
0.27
869.12%
0.51
85.86%
1.78
248.91%
10.68
500.26%
-3.11
129.15%
market cap
514.46M
-
179.33M
65.14%
341.98M
90.70%
392.63M
14.81%
646.86M
64.75%
646.39M
0.07%
748.26M
15.76%
387.70M
48.19%
375.05M
3.26%
105.47M
71.88%
232.46M
120.41%
net current asset value
29.52M
-
103.56M
250.81%
129.07M
24.63%
64.22M
50.24%
113.44M
76.63%
107.66M
5.09%
-66.91M
162.15%
-25.08M
62.51%
-177.08M
605.96%
-157.54M
11.04%
-154.14M
2.16%
net debt to ebitda
1.42
-
0.87
39.28%
0.81
6.31%
1.38
69.75%
0.88
35.70%
0.50
43.12%
0.14
72.84%
0.27
99.06%
0.05
80.95%
-0.20
487.88%
-14.48
7,104.87%
net income per share
-0.68
-
-2.40
251.76%
-2.29
4.57%
-3.60
56.90%
-1.77
50.87%
-1.47
16.82%
-2.36
60.61%
-2.53
6.97%
-1.48
41.60%
-0.58
60.69%
-0.28
52.24%
operating cash flow per share
-0.59
-
-1.78
203.32%
-1.98
10.99%
1.54
177.54%
-1.29
184.09%
-0.83
35.39%
-2.17
160.69%
-0.80
63.34%
-1.52
91.20%
-0.40
73.74%
-0.12
68.83%
payables turnover
0.18
-
3.71
1,963.76%
7.16
93.30%
4.57
36.25%
4.71
3.03%
5.17
9.98%
receivables turnover
0.05
-
5.20
11,361.87%
12.47
139.63%
8.62
30.85%
11.00
27.58%
4.20
61.83%
7.47
77.89%
4.95
33.67%
research and ddevelopement to revenue
75.43
-
1.30
98.28%
1.40
8.00%
0.96
31.19%
0.74
23.26%
0.69
6.43%
0.44
36.26%
0.32
28.40%
return on tangible assets
-0.38
-
-0.33
12.16%
-0.42
27.31%
-0.45
6.45%
-0.21
53.30%
-0.28
32.73%
-0.66
134.81%
-0.79
19.49%
-0.68
14.07%
-0.47
30.18%
-0.35
24.93%
revenue per share
0.04
-
4.09
9,953.38%
1.78
56.56%
2.83
59.20%
2.13
24.62%
1.29
39.66%
1.60
24.38%
1.04
35.15%
roe
-0.43
-
-0.36
16.89%
-0.46
30.26%
-1.99
329.95%
-0.64
67.66%
-0.27
58.06%
-0.71
162.07%
-1.41
99.44%
-3.20
126.67%
-11.35
254.31%
1.70
114.96%
roic
-0.59
-
-0.36
38.20%
-0.47
28.45%
-1.99
327.37%
-0.64
67.84%
-0.23
64.45%
-0.52
129.51%
-0.85
62.90%
-0.92
7.59%
-0.51
44.64%
-0.63
23.57%
sales general and administrative to revenue
14.47
-
0.15
98.95%
0.42
176.39%
0.46
8.88%
0.53
16.68%
0.83
56.10%
0.48
41.71%
0.02
96.57%
shareholders equity per share
1.60
-
6.76
323.23%
4.95
26.74%
1.81
63.51%
2.74
51.89%
5.44
98.33%
3.33
38.72%
1.79
46.36%
0.46
74.24%
0.05
88.91%
-0.16
419.20%
stock based compensation to revenue
3.79
-
0.05
98.69%
0.09
83.97%
0.04
61.16%
0.08
132.69%
0.11
28.52%
0.06
42.69%
0.05
21.52%
tangible asset value
30.76M
-
104.08M
238.41%
131.00M
25.87%
68.12M
48.00%
119.33M
75.18%
252.72M
111.78%
48.49M
80.81%
48.40M
0.20%
-86.72M
279.20%
-117.80M
35.83%
-125.67M
6.69%
tangible book value per share
1.60
-
6.76
323.23%
4.95
26.74%
1.81
63.51%
2.74
51.89%
2.16
21.18%
0.41
81.06%
0.35
14.66%
-0.52
249.52%
-0.64
23.32%
-0.67
4.02%
working capital
29.53M
-
103.59M
250.82%
129.15M
24.67%
182.05M
40.96%
214.01M
17.55%
202.58M
5.34%
101.42M
49.94%
184.29M
81.72%
15.52M
91.58%
60.19M
287.92%
18.28M
69.63%

All numbers in USD (except ratios and percentages)